Reliability of home-based, motor function measure in hereditary neuromuscular diseases.

The measurement of observer agreement for categorical data. Biometrics (1977) 216.56

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull (1968) 20.58

Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res (2011) 3.27

Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology (1989) 1.90

Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther (1992) 1.67

The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol (2003) 1.64

A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord (2005) 1.44

Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain (1997) 1.42

Measures of agreement: a single procedure. Stat Med (1994) 1.36

Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry (2008) 1.36

Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol (2011) 1.32

Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology (2012) 1.31

Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med (2005) 1.22

Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. Phys Ther (1988) 1.15

The context of measuring disability: does it matter whether capability or performance is measured? J Clin Epidemiol (1996) 1.14

Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure. Dev Med Child Neurol (2009) 1.08

Function changes in spinal muscular atrophy II and III. The DCN/SMA Group. Neurology (1996) 1.05

Responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil (2013) 0.89

Use of the Pediatric Outcomes Data Collection Instrument to evaluate functional outcomes in arthrogryposis. J Pediatr Orthop (2011) 0.87

Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse". Neurorehabil Neural Repair (2013) 0.86

Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil (2013) 0.84

Reliability and validity of outcome measures of in-hospital and at-home visits in a randomized, double-blind, placebo-controlled trial for spinal muscular atrophy. J Child Neurol (2013) 0.82

Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies. Neuromuscul Disord (2014) 0.81

Concurrent and discriminant validity of Spanish language instruments for measuring functional health status. J Pediatr Orthop (2008) 0.80

The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease. Ann Phys Rehabil Med (2014) 0.78

Clinical trials in spinal muscular atrophy. Phys Med Rehabil Clin N Am (2008) 0.77

Hip flexion contracture and diminished functional outcomes in cerebral palsy. J Pediatr Orthop (2012) 0.76

Self-perception of quality of life by adolescents with neuromuscular diseases. J Adolesc Health (2009) 0.76